Adding GIP to semaglutide gave no extra benefit in a small six-week trial
A Danish trial in 61 adults with type 2 diabetes, published in The Lancet Diabetes & Endocrinology, found a six-week infusion of native GIP alone or on top of semaglutide did not improve glucose, HbA1c, weight or blood pressure. The authors note the short duration and a 16% dropout rate limit the conclusions.
Image credit: Medical Dialogues
Source: Medical Dialogues (19 Oct 2026).